SEC Says Md. Woman Illegally Traded On FDA Approval Info
The SEC accused a Maryland resident of trading on nonpublic information she received from an insider ahead of the FDA's 2023 denial of a new drug application for a depression treatment...To view the full article, register now.
Already a subscriber? Click here to view full article